Ahmad Alkhalil

Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement

Determine the feasibility and predictors of early discharge after minimalist transcatheter aortic valve replacement (TAVR).

In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease

Transcatheter aortic valve replacement (TAVR) is an alternative to surgical aortic valve replacement (SAVR) for patients with severe symptomatic aortic stenosis (AS) who are at intermediate and high risk for surgery. Commercial use of TAVR has expanded to patients with end stage renal disease (ESRD).

Evaluating the quality of implantation of percutaneous ventricular restoration device (Parachute®) by cardiac computed tomography

The Parachute is a novel percutaneously implanted ventricular partitioning device (VPD) that has emerged as a safe and feasible treatment option for patients with heart failure following anterior wall myocardial infarction. VPD efficacy is likely dependent on optimal device placement, but to date there are no published data examining the effect of device positioning on patient outcomes.